The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectris Regulatory News (SXS)

Share Price Information for Spectris (SXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,306.00
Bid: 3,294.00
Ask: 3,306.00
Change: 0.00 (0.00%)
Spread: 12.00 (0.364%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3,306.00
SXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

26 May 2023 16:43

RNS Number : 8665A
Spectris PLC
26 May 2023
 

Spectris plc

 

Results of the 2023 Annual General Meeting

 

At the Annual General Meeting of Spectris plc held earlier today, all resolutions were voted upon by poll and were passed by shareholders.

 

The full text of each resolution is set out in the Notice of Annual General Meeting, which is available on the Spectris plc website at www.spectris.com.

 

The results of the poll for each resolution are as follows:

 

 

 

 

Resolutions

Votes For

(including Discretionary votes)

Votes Against

Votes Cast

Votes Withheld

Number of shares

%

Number of shares

%

Number of shares

% of relevant shares in issue

Number of shares

1

To receive the Annual Report and Accounts of the Company for the financial year ended 31 December 2022

84,585,306

100.00

282

0.00

84,585,588

80.84%

3,096,518

2

To approve the Directors' Remuneration Report

84,047,913

95.90

3,595,264

4.10

87,643,177

83.76%

38,929

3

Declaration of 2022 Final Dividend

87,657,295

100.00

282

0.00

87,657,577

83.78%

24,529

4

To re-elect Ravi Gopinath as a Non-executive Director of the Company

86,817,551

99.05

833,723

0.95

87,651,274

83.77%

30,832

5

To re-elect Derek Harding as an Executive Director of the Company

86,616,974

98.82

1,034,665

1.18

87,651,639

83.77%

30,467

6

To re-elect Andrew Heath as an Executive Director of the Company

87,645,534

99.99

6,438

0.01

87,651,972

83.77%

30,134

7

To re-elect Alison Henwood as a Non-executive Director of the Company

85,292,245

99.07

800,290

0.93

86,092,535

82.28%

1,589,571

8

To re-elect Ulf Quellmann as a Non-executive Director of the Company

86,833,053

99.07

818,090

0.93

87,651,143

83.77%

30,963

9

To re-elect William (Bill) Seeger as a Non-executive Director of the Company

86,851,985

99.09

799,289

0.91

87,651,274

83.77%

30,832

10

To re-elect Cathy Turner as a Non-executive Director of the Company

86,759,091

98.98

893,358

1.02

87,652,449

83.77%

29,657

11

To re-elect Kjersti Wiklund as a Non-executive Director of the Company

86,844,442

99.08

806,737

0.92

87,651,179

83.77%

30,927

12

To re-elect Mark Williamson as a Non-executive Director of the Company

78,263,239

90.17

8,528,795

9.83

86,792,034

82.95%

890,072

13

To re-appoint Deloitte LLP as auditor of the Company

86,067,510

99.97

25,425

0.03

86,092,935

82.28%

1,589,171

14

To authorise the Directors to agree the auditor's remuneration

87,551,853

99.89

98,614

0.11

87,650,467

83.77%

31,639

15

To authorise the Directors to allot ordinary shares

76,707,738

89.07

9,408,809

10.93

86,116,547

82.30%

1,565,559

16

To empower the Directors to allot ordinary shares for cash on a non pre-emptive basis (Special Resolution)

73,329,193

83.64

14,342,405

16.36

87,671,598

83.79%

10,508

17

To empower the Directors to allot ordinary shares for cash on a non pre-emptive basis for purposes of acquisitions or specified capital investments (Special Resolution)

72,428,608

82.61

15,246,618

17.39

87,675,226

83.79%

6,880

18

To authorise the Company to purchase its own ordinary shares (Special Resolution)

86,054,941

98.19

1,583,002

1.81

87,637,943

83.76%

44,163

19

To authorise the Company to call general meetings (other than annual general meetings) to be not less than 14 clear days' notice (Special Resolution)

83,737,183

95.53

3,916,025

4.47

87,653,208

83.77%

28,898

 

Notes:

The number of Ordinary shares in issue at the close of business on Friday 26 May 2023 (excluding 4,220,344 treasury shares) was 104,612,160.

 

Any vote that gave the Chairman discretion have been included in the 'For' votes. A vote withheld is not a vote in law and is not counted towards the votes cast 'For' or 'Against' a resolution.

 

Pursuant to UK Listing Rule 9.6.2R, copies of the resolutions passed as Special Business at the AGM (resolutions 15 and 16 to 19 inclusive) will shortly be available for inspection at the National Storage Mechanism document viewing facility at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

A copy of the poll results will also be shortly available on the Company's website at www.spectris.com.

 

Name of contact and telephone number for queries:

 

 

Amy Clapton

Deputy Company Secretary

07425 209075

 

For and on behalf of Spectris plc

 

LEI Number: 213800Z4CO2CZO3M3T10

Date: 26 May 2023

 

About Spectris

Spectris combines precision with purpose, delivering progress for a more sustainable world. We provide critical insights to our customers through premium precision measurement solutions combined with technical expertise and deep domain knowledge. Precision is at the heart of what we do - our leading, high-tech instruments and software equip our customers to solve some of their greatest challenges to make the world cleaner, healthier and more productive. Our two, high quality divisions - Spectris Scientific and Spectris Dynamics - are placed in technology-driven end markets, with strong fundamentals and attractive growth trajectories. We have leading market positions in premium segments and employ 7,600 people located in more than 30 countries, all united behind our Purpose to deliver Value Beyond Measure for all our stakeholders. For more information, visit www.spectris.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGEQLFLXELXBBK
Date   Source Headline
2nd May 20247:00 amRNSQ1 2024 trading update
1st May 20249:50 amRNSTotal Voting Rights
23rd Apr 20245:57 pmRNSDirector/PDMR Shareholding
9th Apr 20243:14 pmRNSDirector/PDMR Shareholding
8th Apr 20245:30 pmRNSHolding(s) in Company
3rd Apr 20246:26 pmRNSTransaction in Own Shares
3rd Apr 20245:20 pmRNSHolding(s) in Company
3rd Apr 20247:00 amRNSDivestment of Red Lion Controls completed
2nd Apr 20246:26 pmRNSTransaction in Own Shares
2nd Apr 202410:30 amRNSTotal Voting Rights
28th Mar 20246:29 pmRNSTransaction in Own Shares
28th Mar 202410:00 amRNSDirectorate Change
27th Mar 20245:56 pmRNSTransaction in Own Shares
27th Mar 20249:45 amRNSAnnual Financial Report
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20246:23 pmRNSTransaction in Own Shares
20th Mar 20246:44 pmRNSTransaction in Own Shares
20th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20245:59 pmRNSTransaction in Own Shares
18th Mar 202411:37 amRNSDirector and Board Committee Membership Change
15th Mar 20246:10 pmRNSTransaction in Own Shares
15th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20246:28 pmRNSTransaction in Own Shares
12th Mar 20246:06 pmRNSTransaction in Own Shares
11th Mar 20246:02 pmRNSTransaction in Own Shares
11th Mar 202412:33 pmRNSDirector/PDMR Shareholding
8th Mar 20246:00 pmRNSTransaction in Own Shares
8th Mar 20242:59 pmRNSDirector/PDMR Shareholding
7th Mar 20245:27 pmRNSTransaction in Own Shares
7th Mar 202411:32 amRNSDirector Declaration
6th Mar 20246:07 pmRNSTransaction in Own Shares
5th Mar 20246:03 pmRNSTransaction in Own Shares
4th Mar 20245:48 pmRNSTransaction in Own Shares
1st Mar 20246:04 pmRNSTransaction in Own Shares
1st Mar 202410:00 amRNSTotal Voting Rights
1st Mar 20247:46 amRNSDirector Declaration
29th Feb 20246:02 pmRNSTransaction in Own Shares
29th Feb 20247:00 amRNSFinal Results
28th Feb 20246:05 pmRNSTransaction in Own Shares
27th Feb 20246:04 pmRNSTransaction in Own Shares
26th Feb 20245:59 pmRNSTransaction in Own Shares
23rd Feb 20246:03 pmRNSTransaction in Own Shares
22nd Feb 20245:34 pmRNSTransaction in Own Shares
21st Feb 20245:58 pmRNSTransaction in Own Shares
20th Feb 20245:41 pmRNSTransaction in Own Shares
19th Feb 20245:38 pmRNSTransaction in Own Shares
16th Feb 20245:58 pmRNSTransaction in Own Shares
15th Feb 20246:05 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.